Today, I realize that this was all smoke and mirrors and that I have been wrong.
I especially like the part where the office furniture is put under scrutiny. That was an eye opener for me. Never would I have gotten the ida of researching such a vital and important part of the business. I now fear that the latest surge in share price was not due to the FDA granting Brilacidin QIDP designation but merely a matter of speculation based on an unrealistic valuation of the 25 hight adjustable desks and the almost new canteen vending machine.
Mine is right before yours. Put Karins back in there too about the email. So far it's still there. Didn't have time for more, maybe later this weekend.